Moors & Cabot’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.33M | Buy |
26,594
+471
| +2% | +$130K | 0.34% | 63 |
|
|
2025
Q1 | $6.93M | Sell |
26,123
-1,366
| -5% | -$362K | 0.35% | 57 |
|
|
2024
Q4 | $6.38M | Buy |
27,489
+217
| +0.8% | +$50.4K | 0.3% | 66 |
|
|
2024
Q3 | $6.02M | Sell |
27,272
-4,180
| -13% | -$922K | 0.3% | 70 |
|
|
2024
Q2 | $6.18M | Buy |
31,452
+2,853
| +10% | +$561K | 0.33% | 62 |
|
|
2024
Q1 | $6.16M | Buy |
28,599
+267
| +0.9% | +$57.5K | 0.33% | 64 |
|
|
2023
Q4 | $5.97M | Buy |
28,332
+115
| +0.4% | +$24.2K | 0.37% | 58 |
|
|
2023
Q3 | $5.65M | Buy |
28,217
+258
| +0.9% | +$51.7K | 0.38% | 55 |
|
|
2023
Q2 | $5.18M | Buy |
27,959
+1,727
| +7% | +$320K | 0.34% | 65 |
|
|
2023
Q1 | $5.02M | Sell |
26,232
-33
| -0.1% | -$6.32K | 0.35% | 65 |
|
|
2022
Q4 | $4.42M | Buy |
26,265
+1,194
| +5% | +$201K | 0.31% | 77 |
|
|
2022
Q3 | $4.44M | Buy |
25,071
+774
| +3% | +$137K | 0.34% | 70 |
|
|
2022
Q2 | $4.97M | Buy |
24,297
+1,031
| +4% | +$211K | 0.36% | 63 |
|
|
2022
Q1 | $5.53M | Buy |
23,266
+893
| +4% | +$212K | 0.34% | 65 |
|
|
2021
Q4 | $5.11M | Buy |
22,373
+654
| +3% | +$149K | 0.31% | 71 |
|
|
2021
Q3 | $4.22M | Buy |
21,719
+3,444
| +19% | +$670K | 0.27% | 86 |
|
|
2021
Q2 | $3.89M | Buy |
18,275
+7,576
| +71% | +$1.61M | 0.27% | 84 |
|
|
2021
Q1 | $2.17M | Buy |
10,699
+1,087
| +11% | +$220K | 0.17% | 137 |
|
|
2020
Q4 | $1.75M | Sell |
9,612
-861
| -8% | -$157K | 0.15% | 150 |
|
|
2020
Q3 | $1.75M | Buy |
10,473
+8,600
| +459% | +$1.44M | 0.17% | 134 |
|
|
2020
Q2 | $304K | Sell |
1,873
-284
| -13% | -$46.1K | 0.03% | 443 |
|
|
2020
Q1 | $372K | Buy |
2,157
+36
| +2% | +$6.21K | 0.05% | 310 |
|
|
2019
Q4 | $426K | Sell |
2,121
-41
| -2% | -$8.24K | 0.04% | 382 |
|
|
2019
Q3 | $363K | Buy |
+2,162
| New | +$363K | 0.04% | 397 |
|